Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.
Twitter handle: @jeffmason1
TEL AVIV Israeli shares jumped nearly 2 percent on Sunday after Standard & Poor's upgraded the country's sovereign debt rating, and analysts said that in the short term the move would boost stocks, bonds and the shekel.
TEL AVIV Teva Pharmaceutical Industries on Thursday raised its profit outlook for 2018 after reporting a smaller than expected drop in second-quarter net profit, but its shares tumbled eight percent on disappointment over its unchanged revenue outlook.
TEL AVIV Network security provider Check Point Software Technologies reported a better-than-expected second quarter net profit and doubled its overall share repurchase program on Wednesday to $2 billion.
REHOVOT, Israel Israeli defense firm Elbit Systems on Thursday unveiled a 1.6 ton unmanned aircraft vehicle (UAV) designed to fly in airspace currently reserved for piloted civilian planes as a race heats up to deploy military drones outside combat zones.
TEL AVIV A former employee of cyber surveillance company NSO Group has been charged with stealing intellectual property and trying to sell it for $50 million over the Darknet in a manner that could harm state security, Israel's Justice Ministry said.
TEL AVIV BrainStorm Cell Therapeutics Inc will not make its experimental stem cell treatment for neurodegenerative diseases available under the new U.S. "Right to Try" (RTT) act, citing a failure to find a way to enable all patients to afford the treatment.
TEL AVIV Cybersecurity firm McAfee is looking at further acquisitions after buying security provider SkyHigh Networks this year and has not ruled out going public again to widen its options, its chief executive said.
RAANANA, Israel Israel's UroGen Pharma plans to begin a mid-stage trial of its treatment for bladder cancer patients in August, after positive interim results last month from an advanced trial of a treatment for upper urinary tract cancer.
SHFAYIM, Israel Technology that has helped Israel's military drive tanks, guide and intercept missiles, and keep its computer systems secure is being redeployed in the development of driverless cars.
TEL AVIV The Renault-Nissan-Mitsubishi alliance's new venture capital fund has agreed five investments in four months totaling $50 million and will present another to its supervisory board next week, the fund's head said.